February 17, 2015
Now BATting: A New Treatment Approach That Uses Testosterone First, Then ADTEmma Shtivelman, PhD
Androgen deprivation therapy (ADT) has long been a mainstay in the management of prostate cancer. Indeed, the vast majority of prostate cancers depend on androgens (hormones like testosterone) for their growth. Lowering testosterone levels with ADT is a reasonable approach. But it comes with two sets of problems.